ParanoiaNCT07460453
Racial Disparities in the Expression of Paranoia
A study testing Guided Visual Imagery Task in people with Paranoia and Psychotic Disorders, run by Indiana University at 1 site in United States.
Trial summary
Paranoia is a pattern of thinking in which people feel suspicious or believe others may want to harm them. It can occur in many people, not only those with a mental health diagnosis, and it can affect daily life, relationships, and overall well-being. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Paranoia, Psychotic Disorders
- What is being tested?
- Guided Visual Imagery Task
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 480 participants
- Where
- 1 siteUnited States
- Study dates
- 13 Apr 2026to 30 Jun 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- 18 years of age or older
- Self-identify as non-Hispanic Black or African American
- Currently reside in the United States
- Speak and read English
- Registered as a survey participant on the Prolific platform
Who cannot join
- Younger than 18 years of age
- Do not self-identify as non-Hispanic Black or African American
- Do not currently reside in the United States
- Do not speak or read English
- Not registered as a survey participant on the Prolific platform
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Department of Psychological and Brain Sciences
Bloomington, Indiana, 47405
William P Hetrick, 8128552620, whetrick@iu.edu
J Wolny, 8128552620, wolny@iu.edu
About this study
Official title: Study of Life Challenges, Personality, and Emotional Experiences
Paranoia is a pattern of thinking in which people feel suspicious or believe others may want to harm them. It can occur in many people, not only those with a mental health diagnosis, and it can affect daily life, relationships, and overall well-being. Research has consistently shown that Black Americans report higher levels of paranoia than White Americans, even when they do not have a clinical diagnosis. However, the reasons for this difference are not well understood.
The goal of this study is to better understand why these differences exist. In the experimental part of the study, researchers will use a randomized design to test whether exposure to stressful experiences related to race leads to higher levels of paranoia among Black American participants. The study will also examine factors that may strengthen or weaken this effect, such as individual experiences and personal characteristics.
By identifying how stressful experiences related to race influence paranoia, this research aims to improve how paranoia is measured and understood across different groups. These findings may help researchers and clinicians use more accurate and culturally appropriate tools to assess psychosis-related experiences in diverse populations.
Read the detailed description
Paranoia, a core symptom of psychosis, is characterized by beliefs of being threatened, persecuted, or conspiratorially targeted. In contemporary psychological approaches, paranoia is defined as a dimensional and transdiagnostic construct existing on a continuum of severity throughout the population and conferring risk for negative outcomes including impairments in social functioning, well-being, and quality of life.
Despite its centrality in understanding the psychosis spectrum, including clinical conditions such as schizophrenia, paranoia is a construct vulnerable to various individual- and group-level influences. Social threats experienced by some groups may rightfully compel increased mistrust and suspiciousness of others. In fact, numerous cross-sectional investigations demonstrate that Black Americans consistently endorse higher levels of paranoia compared to their White counterparts, independent of clinical status. Furthermore, emerging evidence indicates a positive association between adverse experiences related to race and increased paranoia endorsements among Black Americans.
This project addresses the insufficient understanding of factors contributing to group differences in paranoia between Black and White Americans. Moreover, existing evidence linking adverse experiences related to race and heightened paranoia among Black Americans is correlational; possible causal pathways have not been examined through experimental means. This knowledge gap is significant because Black Americans endorse heightened traits and experiences associated with psychosis across the severity spectrum, ultimately leading to a three- to fourfold higher diagnostic rate of psychotic disorders compared to their White counterparts. Importantly, current assessment tools may systematically mischaracterize psychosis risk among Black Americans across this severity spectrum in both research and clinical practice, as they were not designed to account for the potential confounding impact of adverse experiences related to race on item endorsements among diverse respondents. Errors in measurement-which may stem from poor cultural sensitivity and be sustained by a paucity of knowledge of how social threats may impact the phenotypic expression of psychosis-have been implicated as one potential cause of the overrepresentation of Black Americans within psychotic disorder diagnoses. This theory is compatible with other potential mechanisms, including inequities in social determinants of health driving true increases in psychotic disorders among Black Americans. Consequently, there is a high likelihood that assessment tools systematically conflate culturally justified mistrust with psychopathological symptomology across this severity spectrum, making accurate assessment of paranoia among diverse respondents a pressing clinical concern. Accordingly, this project focuses on self-reported paranoia among Black and White adults in the general population.
The primary objective of this study is to experimentally test whether exposure to race-related adverse experiences results in acute increases in self-reported paranoia. Our first goal is to experimentally test the causal impact of adverse experiences related to race on paranoia among Black Americans by examining the extent to which paranoia can be increased following priming exposure to blatant and subtle adverse experiences related to race using a guided visual imagery paradigm. Study participants, comprising 480 Black American adults recruited from the community, will engage in a guided visual imagery task that involves actively envisioning scenarios presented via audiotape-an established method for priming race-related stressors in controlled experimental settings. Participants will be randomly assigned to one of three conditions: blatant adverse experience, subtle adverse experience, social exclusion, or neutral control. Primary outcomes include changes in self-reported paranoia following experimental exposure. It is hypothesized that priming adverse experiences related to race will drive significant increases in self-reported paranoia compared to the neutral control condition.
A secondary objective of this study is to identify individual-level risk and resilience factors that influence variability in experimentally induced changes in paranoia. A subsequent goal will identify risk and resilience factors that may influence the magnitude of the experimental effects observed in Goal 1. Using data collected within the same experimental framework, it is hypothesized that self-reported adverse experiences related to race, in addition to race and ethnicity, will moderate paranoia endorsements observed among Black Americans following experimental exposure to race-related adverse experiences.
- Conditions
- Paranoia, Psychotic Disorders
- Being tested
- Guided Visual Imagery Task
- Keywords
- Paranoia, Psychosis-Spectrum, Adverse Experiences, Experimental Paradigm, General Population
- Medical subject headings
- Paranoid Disorders, Psychotic Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Guided Visual Imagery TaskBehavioural
Participants complete an online, audio-guided visual imagery task designed to experimentally prime social experiences under standardized conditions. After brief instructions to imagine themselves actively participating in each scene, participants complete practice trials with neutral content and then are randomized to listen to one audio-recorded scenario matched to their assigned condition. Each trial includes a brief relaxation period, an instruction period, a guided imagery listening period, and a short recovery period. Scenarios are approximately 30 seconds and are delivered via headphones/speakers within the survey platform. Following the imagery task, participants complete post-task self-report assessments capturing current (state) experiences, including state paranoia and manipulation checks (e.g., imagery vividness and task engagement). The task is administered once in a single session.
| Study group | Role | What they receive |
|---|---|---|
| Blatant Race-Related Adverse Experience Imagery | Experimental | Participants are exposed to an audio-guided imagery scenario depicting a blatant race-related adverse experience. The guided imagery task instructs participants to vividly imagine a situation involving explicit racial hostility or discrimination. This intervention is designed to experimentally prime exposure to overt race-related social threat in a controlled setting. Receives: Behavioral: Guided Visual Imagery Task |
| Subtle Race-Related Adverse Experience Imagery | Experimental | Participants are exposed to an audio-guided imagery scenario depicting a subtle race-related adverse experience, such as ambiguous or indirect racial bias. The guided imagery task instructs participants to imagine a situation involving covert or nuanced race-related social threat, consistent with commonly reported microaggressive experiences. Receives: Behavioral: Guided Visual Imagery Task |
| Neutral Control Imagery | Placebo comparator | Participants are exposed to an audio-guided imagery scenario depicting a neutral, non-threatening experience unrelated to race or social evaluation. This condition serves as a control for engagement with the guided imagery task without exposure to race-related adverse content. Receives: Behavioral: Guided Visual Imagery Task |
| Social Exclusion Imagery | Experimental | Participants listen to an audio-guided imagery scenario depicting social exclusion (e.g., being left out or rejected in a social context) without reference to race and are instructed to vividly imagine the situation. This condition isolates the effect of social threat/exclusion from race-specific content. Receives: Behavioral: Guided Visual Imagery Task |
What is being measured
The primary outcome is the main question the study is designed to answer.
State Paranoia
Self-reported paranoia will be assessed immediately following the experimental task to capture acute, experimentally induced changes in paranoia. State paranoia will be measured using the Revised Green Paranoid Thought Scale (R-GPTS; Green et al., 2019), an 18-item validated Likert-type measure appropriate for clinical and nonclinical samples. Scores range from 0-72, with higher scores indicating greater state paranoia. The R-GPTS includes two subscales: (1) Ideas of Reference and (2) Ideas of Persecution. Items are summed to generate subscale and total scores. The scale demonstrates excellent internal consistency (α > .90), and prior work (Wolny et al., revisions submitted) established measurement invariance across Black and White American participants.
Measured: Immediately post-intervention (single session)
Secondary outcomes (1)
Affective Response
Self-reported affective responses will be assessed before and after the experimental task to characterize changes in emotional valence and arousal following exposure to the guided imagery scenarios. Affect will be measured using two Self-Assessment Manikin (SAM; Bradley \& Lang, 1994) single-item ratings: (1) Valence, ranging from 1 (Unpleasant) to 9 (Very pleasant), with higher scores indicating more pleasant affect; and (2) Arousal, ranging from 1 (Calm) to 9 (Aroused), with higher scores indicating greater emotional activation.
Measured: Pre-intervention and immediately post-intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Mar 2026
- Study start13 Apr 2026
- Primary completion30 Jun 2026 (estimated)
- Study completion30 Jun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ParanoiaStudies of the same condition, open and under way.
- More trials run by Indiana UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 480 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Indiana University
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute of Mental Health (NIMH)
- Responsible party
- Principal investigator, Bill Hetrick, Indiana University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07460453
- Sponsor's protocol ID
- 25650
- Other IDs
- F31MH135692
- Status last verified
- Apr 2026
- First submitted
- 4 Mar 2026
- Last updated
- 29 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be publicly shared. Due to the sensitive nature of the data collected, individual-level data are not planned for open distribution. De-identified aggregate results will be reported in publications. Potential data collaborations may be considered on a case-by-case basis, subject to institutional and ethical review.
Study at a glance
From the registry record, last updated by the sponsor on 29 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Study of Life Challenges, Personality, and Emotional Experiences
- ClinicalTrials.gov ID
- NCT07460453
- Acronym / sponsor ID
- 25650
- Conditions
- Paranoia, Psychotic Disorders
- Keywords
- Paranoia, Psychosis-Spectrum, Adverse Experiences, Experimental Paradigm, General Population
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 480 participants (estimated)
- Lead sponsor
- Indiana UniversityUniversity, hospital or other
- Collaborators
- National Institute of Mental Health (NIMH)
- Study start
- 13 Apr 2026 (actual)
- Primary completion
- 30 Jun 2026 (estimated)
- Study completion
- 30 Jun 2026 (estimated)
- First posted
- 10 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Paranoia is a pattern of thinking in which people feel suspicious or believe others may want to harm them. It can occur in many people, not only those with a mental health diagnosis, and it can affect daily life, relationships, and overall well-being. Research has consistently shown that Black Americans report higher levels of paranoia than White Americans, even when they do not have a clinical diagnosis. However, the reasons for this difference are not well understood.
The goal of this study is to better understand why these differences exist. In the experimental part of the study, researchers will use a randomized design to test whether exposure to stressful experiences related to race leads to higher levels of paranoia among Black American participants. The study will also examine factors that may strengthen or weaken this effect, such as individual experiences and personal characteristics.
By identifying how stressful experiences related to race influence paranoia, this research aims to improve how paranoia is measured and understood across different groups. These findings may help researchers and clinicians use more accurate and culturally appropriate tools to assess psychosis-related experiences in diverse populations.
Detailed description
Paranoia, a core symptom of psychosis, is characterized by beliefs of being threatened, persecuted, or conspiratorially targeted. In contemporary psychological approaches, paranoia is defined as a dimensional and transdiagnostic construct existing on a continuum of severity throughout the population and conferring risk for negative outcomes including impairments in social functioning, well-being, and quality of life.
Despite its centrality in understanding the psychosis spectrum, including clinical conditions such as schizophrenia, paranoia is a construct vulnerable to various individual- and group-level influences. Social threats experienced by some groups may rightfully compel increased mistrust and suspiciousness of others. In fact, numerous cross-sectional investigations demonstrate that Black Americans consistently endorse higher levels of paranoia compared to their White counterparts, independent of clinical status. Furthermore, emerging evidence indicates a positive association between adverse experiences related to race and increased paranoia endorsements among Black Americans.
This project addresses the insufficient understanding of factors contributing to group differences in paranoia between Black and White Americans. Moreover, existing evidence linking adverse experiences related to race and heightened paranoia among Black Americans is correlational; possible causal pathways have not been examined through experimental means. This knowledge gap is significant because Black Americans endorse heightened traits and experiences associated with psychosis across the severity spectrum, ultimately leading to a three- to fourfold higher diagnostic rate of psychotic disorders compared to their White counterparts. Importantly, current assessment tools may systematically mischaracterize psychosis risk among Black Americans across this severity spectrum in both research and clinical practice, as they were not designed to account for the potential confounding impact of adverse experiences related to race on item endorsements among diverse respondents. Errors in measurement-which may stem from poor cultural sensitivity and be sustained by a paucity of knowledge of how social threats may impact the phenotypic expression of psychosis-have been implicated as one potential cause of the overrepresentation of Black Americans within psychotic disorder diagnoses. This theory is compatible with other potential mechanisms, including inequities in social determinants of health driving true increases in psychotic disorders among Black Americans. Consequently, there is a high likelihood that assessment tools systematically conflate culturally justified mistrust with psychopathological symptomology across this severity spectrum, making accurate assessment of paranoia among diverse respondents a pressing clinical concern. Accordingly, this project focuses on self-reported paranoia among Black and White adults in the general population.
The primary objective of this study is to experimentally test whether exposure to race-related adverse experiences results in acute increases in self-reported paranoia. Our first goal is to experimentally test the causal impact of adverse experiences related to race on paranoia among Black Americans by examining the extent to which paranoia can be increased following priming exposure to blatant and subtle adverse experiences related to race using a guided visual imagery paradigm. Study participants, comprising 480 Black American adults recruited from the community, will engage in a guided visual imagery task that involves actively envisioning scenarios presented via audiotape-an established method for priming race-related stressors in controlled experimental settings. Participants will be randomly assigned to one of three conditions: blatant adverse experience, subtle adverse experience, social exclusion, or neutral control. Primary outcomes include changes in self-reported paranoia following experimental exposure. It is hypothesized that priming adverse experiences related to race will drive significant increases in self-reported paranoia compared to the neutral control condition.
A secondary objective of this study is to identify individual-level risk and resilience factors that influence variability in experimentally induced changes in paranoia. A subsequent goal will identify risk and resilience factors that may influence the magnitude of the experimental effects observed in Goal 1. Using data collected within the same experimental framework, it is hypothesized that self-reported adverse experiences related to race, in addition to race and ethnicity, will moderate paranoia endorsements observed among Black Americans following experimental exposure to race-related adverse experiences.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Blatant Race-Related Adverse Experience Imagery | Experimental | Behavioral: Guided Visual Imagery TaskParticipants are exposed to an audio-guided imagery scenario depicting a blatant race-related adverse experience. The guided imagery task instructs participants to vividly imagine a situation involving explicit racial hostility or discrimination. This intervention is designed to experimentally prime exposure to overt race-related social threat in a controlled setting. |
| Subtle Race-Related Adverse Experience Imagery | Experimental | Behavioral: Guided Visual Imagery TaskParticipants are exposed to an audio-guided imagery scenario depicting a subtle race-related adverse experience, such as ambiguous or indirect racial bias. The guided imagery task instructs participants to imagine a situation involving covert or nuanced race-related social threat, consistent with commonly reported microaggressive experiences. |
| Neutral Control Imagery | Placebo comparator | Behavioral: Guided Visual Imagery TaskParticipants are exposed to an audio-guided imagery scenario depicting a neutral, non-threatening experience unrelated to race or social evaluation. This condition serves as a control for engagement with the guided imagery task without exposure to race-related adverse content. |
| Social Exclusion Imagery | Experimental | Behavioral: Guided Visual Imagery TaskParticipants listen to an audio-guided imagery scenario depicting social exclusion (e.g., being left out or rejected in a social context) without reference to race and are instructed to vividly imagine the situation. This condition isolates the effect of social threat/exclusion from race-specific content. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- 18 years of age or older
- Self-identify as non-Hispanic Black or African American
- Currently reside in the United States
- Speak and read English
- Registered as a survey participant on the Prolific platform
Key exclusion criteria (5 listed)
- Younger than 18 years of age
- Do not self-identify as non-Hispanic Black or African American
- Do not currently reside in the United States
- Do not speak or read English
- Not registered as a survey participant on the Prolific platform
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Guided Visual Imagery TaskParticipants complete an online, audio-guided visual imagery task designed to experimentally prime social experiences under standardized conditions. After brief instructions to imagine themselves actively participating in each scene, participants complete practice trials with neutral content and then are randomized to listen to one audio-recorded scenario matched to their assigned condition. Each trial includes a brief relaxation period, an instruction period, a guided imagery listening period, and a short recovery period. Scenarios are approximately 30 seconds and are delivered via headphones/speakers within the survey platform. Following the imagery task, participants complete post-task self-report assessments capturing current (state) experiences, including state paranoia and manipulation checks (e.g., imagery vividness and task engagement). The task is administered once in a single session. | Behavioural | Blatant Race-Related Adverse Experience Imagery, Neutral Control Imagery, Social Exclusion Imagery, Subtle Race-Related Adverse Experience Imagery |
Primary outcome
State Paranoia
Time frame: Immediately post-intervention (single session)
Self-reported paranoia will be assessed immediately following the experimental task to capture acute, experimentally induced changes in paranoia. State paranoia will be measured using the Revised Green Paranoid Thought Scale (R-GPTS; Green et al., 2019), an 18-item validated Likert-type measure appropriate for clinical and nonclinical samples. Scores range from 0-72, with higher scores indicating greater state paranoia. The R-GPTS includes two subscales: (1) Ideas of Reference and (2) Ideas of Persecution. Items are summed to generate subscale and total scores. The scale demonstrates excellent internal consistency (α > .90), and prior work (Wolny et al., revisions submitted) established measurement invariance across Black and White American participants.
1 secondary outcome
Affective Response
Time frame: Pre-intervention and immediately post-intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Apr 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be publicly shared. Due to the sensitive nature of the data collected, individual-level data are not planned for open distribution. De-identified aggregate results will be reported in publications. Potential data collaborations may be considered on a case-by-case basis, subject to institutional and ethical review.
Related trials for Paranoia
Recruiting
Supporting Patients by Family Education in Psychotic Illness: A Prospective Cohort Study
Psychotic Disorders, Family Members
Not yet recruitingPhase 2
An Investigation of Mechanisms That Underly Paranoia in Behaviour and Brain That Can Inform Clinical Diagnoses That Include Paranoid Symptoms.
None Volunteer
Recruiting
Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy
Schizophrenia Disorders
RecruitingObservational study
Immune Mechanisms of Antipsychotic Treatment Response
Psychosis
Recruiting
Acceptability and Feasibility of a Brief Paranoia Intervention.
Paranoia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Guided Visual Imagery Task in people with Paranoia and Psychotic Disorders, run by Indiana University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 29 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact J Wolny (812-855-2620, wolny@iu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
State Paranoia (time frame: Immediately post-intervention (single session)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2026.